Your browser doesn't support javascript.
loading
Randomized Controlled Trial of Urokinase versus Placebo for Nondraining Malignant Pleural Effusion.
Mishra, Eleanor K; Clive, Amelia O; Wills, Genevieve H; Davies, Helen E; Stanton, Andrew E; Al-Aloul, Mohamed; Hart-Thomas, Alan; Pepperell, Justin; Evison, Matthew; Saba, Tarek; Harrison, Richard Neil; Guhan, Anur; Callister, Matthew E; Sathyamurthy, Ramamurthy; Rehal, Sunita; Corcoran, John P; Hallifax, Robert; Psallidas, Ioannis; Russell, Nicky; Shaw, Rachel; Dobson, Melissa; Wrightson, John M; West, Alex; Lee, Y C Gary; Nunn, Andrew J; Miller, Robert F; Maskell, Nick A; Rahman, Najib M.
Afiliación
  • Mishra EK; 1 Norfolk and Norwich Pleural Unit, Norfolk and Norwich University Hospital NHS Foundation Trust, Norfolk, United Kingdom.
  • Clive AO; 2 Academic Respiratory Unit, School of Clinical Sciences, Southmead Hospital, University of Bristol, Bristol, United Kingdom.
  • Wills GH; 3 Medical Research Council Clinical Trials Unit and.
  • Davies HE; 4 Cardiff and Vale University Health Board, Cardiff, United Kingdom.
  • Stanton AE; 5 Great Western Hospital, Swindon, United Kingdom.
  • Al-Aloul M; 6 University Hospital of South Manchester NHS Foundation Trust, Manchester, United Kingdom.
  • Hart-Thomas A; 7 Calderdale and Huddersfield NHS Foundation Trust, Huddersfield, United Kingdom.
  • Pepperell J; 8 Somerset Lung Centre, Musgrove Park Hospital, Taunton, United Kingdom.
  • Evison M; 6 University Hospital of South Manchester NHS Foundation Trust, Manchester, United Kingdom.
  • Saba T; 9 Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, United Kingdom.
  • Harrison RN; 10 North Tees and Hartlepool Hospitals NHS Foundation Trust, North Tees, United Kingdom.
  • Guhan A; 11 University Hospital Ayr, Ayr, United Kingdom.
  • Callister ME; 12 Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
  • Sathyamurthy R; 13 James Cook University Hospital, South Tees, United Kingdom.
  • Rehal S; 3 Medical Research Council Clinical Trials Unit and.
  • Corcoran JP; 14 Oxford Respiratory Trials Unit and Oxford Pleural Diseases Unit, Churchill Hospital, Oxford, United Kingdom.
  • Hallifax R; 14 Oxford Respiratory Trials Unit and Oxford Pleural Diseases Unit, Churchill Hospital, Oxford, United Kingdom.
  • Psallidas I; 14 Oxford Respiratory Trials Unit and Oxford Pleural Diseases Unit, Churchill Hospital, Oxford, United Kingdom.
  • Russell N; 14 Oxford Respiratory Trials Unit and Oxford Pleural Diseases Unit, Churchill Hospital, Oxford, United Kingdom.
  • Shaw R; 14 Oxford Respiratory Trials Unit and Oxford Pleural Diseases Unit, Churchill Hospital, Oxford, United Kingdom.
  • Dobson M; 14 Oxford Respiratory Trials Unit and Oxford Pleural Diseases Unit, Churchill Hospital, Oxford, United Kingdom.
  • Wrightson JM; 14 Oxford Respiratory Trials Unit and Oxford Pleural Diseases Unit, Churchill Hospital, Oxford, United Kingdom.
  • West A; 15 Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
  • Lee YCG; 16 School of Medicine and Pharmacology, University of Western Australia, Perth, Australia; and.
  • Nunn AJ; 3 Medical Research Council Clinical Trials Unit and.
  • Miller RF; 17 Research Department of Infection and Population Health, Institute of Epidemiology and Healthcare, University College London, London, United Kingdom.
  • Maskell NA; 2 Academic Respiratory Unit, School of Clinical Sciences, Southmead Hospital, University of Bristol, Bristol, United Kingdom.
  • Rahman NM; 14 Oxford Respiratory Trials Unit and Oxford Pleural Diseases Unit, Churchill Hospital, Oxford, United Kingdom.
Am J Respir Crit Care Med ; 197(4): 502-508, 2018 02 15.
Article en En | MEDLINE | ID: mdl-28926296
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Activador de Plasminógeno de Tipo Uroquinasa / Derrame Pleural Maligno Tipo de estudio: Clinical_trials / Observational_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Am J Respir Crit Care Med Asunto de la revista: TERAPIA INTENSIVA Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Activador de Plasminógeno de Tipo Uroquinasa / Derrame Pleural Maligno Tipo de estudio: Clinical_trials / Observational_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Am J Respir Crit Care Med Asunto de la revista: TERAPIA INTENSIVA Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido